Effect of the branched-chain α-keto acids accumulating in maple syrup urine disease on S100B release from glial cells

详细信息    查看全文

• 作者：Clá ; udia Funchal ; Francine Tramontina ; André ; Quincozes dos Santos ; Daniela Fraga de Souza ; Carlos Alberto Gonç ; alves ; Regina Pessoa-Pureur ; Moacir Wajner
• 关键词：Branched-chain α ; -keto acids ; Maple syrup urine disease ; S100B ; Antioxidants ; Creatine ; Kinase inhibitors
• 刊名：Journal of the Neurological Sciences
• 出版年：2007
• 出版时间：15 September 2007
• 年：2007
• 卷：260
• 期：1-2
• 页码：87-94
• 全文大小：574 K

文摘

Accumulation of the branched-chain α-keto acids (BCKA), α-ketoisocaproic acid (KIC), α-keto-β-methylvaleric acid (KMV) and α-ketoisovaleric acid (KIV) and their respective branched-chain α-amino acids (BCAA) occurs in tissues and biological fluids of patients affected by the neurometabolic disorder maple syrup urine disease (MSUD). The objective of this study was to verify the effect of the BCKA on S100B release from C6 glioma cells. The cells were exposed to 1, 5 or 10 mM BCKA for different periods and the S100B release was measured afterwards. The results indicated that KIC and KIV, but not KMV, significantly enhanced S100B liberation after 6 h of exposure. Furthermore, the stimulatory effect of the BCKA on S100B release was prevented by coincubation with the energetic substrate creatine and with the N-nitro-l-arginine methyl ester (l-NAME), a nitric oxide synthase inhibitor, indicating that energy deficit and nitric oxide (NO) were probably involved in this effect. Furthermore, the increase of S100B release was prevented by preincubation with the protein kinase inhibitors KN-93 and H-89, indicating that KIC and KIV altered Ca²⁺/calmodulin (PKCaMII)- and cAMP (PKA)-dependent protein kinases activities, respectively. In contrast, other antioxidants such as glutathione (GSH) and trolox (soluble vitamin E) were not able to prevent KIC- and KIV-induced increase of S100B liberation, suggesting that the alteration of S100B release caused by the BCKA is not mediated by oxidation of sulfydryl or other essential groups of the enzyme as well as by lipid peroxyl radicals. Considering the importance of S100B for brain regulation, it is conceivable that enhanced liberation of this protein by increased levels of BCKA may contribute to the neurodegeneration characteristic of MSUD patients.